Canterbury Park director granted 2,547 deferred shares

OFFERMAN CARIN J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

OFFERMAN CARIN J reported acquisition or exercise transactions in this Form 4 filing.

Canterbury Park Holding Corp director Carin J. Offerman received a deferred stock award of 2,547 shares of common stock. This grant was awarded at no cash cost per share and increases her direct holdings to 118,852 shares. The award will vest at the company’s 2027 Annual Meeting of Shareholders and the shares will be delivered one year after the vesting date. The number of shares was based on the closing stock price of $15.70 on June 4, 2026.

Insider Trade Summary

Grant/Award: 2,547 shares

Grant/Award 1 txn

Insider OFFERMAN CARIN J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,547	$0.00	$0.00

Holdings After Transaction: Common Stock — 118,852 shares (Direct)

Footnotes (1)

1. F1. Deferred stock award vesting at the Company's 2027 Annual Meeting of Shareholders, but not delivered until one year from the vesting date. The number of shares to be issued was determined based on the closing price of $15.70 as of June 4, 2026.

Key Figures

Deferred stock award: 2,547 shares Closing price reference: $15.70 Post-transaction holdings: 118,852 shares +2 more

5 metrics

Deferred stock award 2,547 shares Grant of common stock as deferred award

Closing price reference $15.70 Closing price on June 4, 2026 used to size award

Post-transaction holdings 118,852 shares Total common stock held directly after grant

Vesting event 2027 Annual Meeting Award vests at 2027 Annual Meeting of Shareholders

Delivery timing 1 year after vesting Shares delivered one year after vesting date

Key Terms

Deferred stock award, vesting, Annual Meeting of Shareholders, closing price, +1 more

5 terms

Deferred stock award financial

"Deferred stock award vesting at the Company's 2027 Annual Meeting of Shareholders"

A deferred stock award is company stock granted to employees or executives but delivered or allowed to be sold at a later date, often after meeting time or performance conditions. For investors, it matters because these promised shares can increase the number of outstanding shares (dilution) and reveal how management is being paid and motivated; think of it as a delayed paycheck in stock form that aligns long-term incentives.

vesting financial

"vesting at the Company's 2027 Annual Meeting of Shareholders, but not delivered until one year"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Annual Meeting of Shareholders financial

"vesting at the Company's 2027 Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

closing price financial

"The number of shares to be issued was determined based on the closing price of $15.70"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Canterbury Park (CPHC) report for Carin J. Offerman?

Canterbury Park reported that director Carin J. Offerman received a deferred stock award of 2,547 shares of common stock. This grant is compensation-related, carries no cash exercise price, and increases her direct holdings to 118,852 shares following the transaction.

At what price was Carin J. Offerman’s CPHC deferred stock award calculated?

The deferred stock award for Carin J. Offerman was calculated using a closing share price of $15.70 as of June 4, 2026. This price determined how many shares equaled the award’s value, resulting in a grant of 2,547 shares of common stock.

When will Carin J. Offerman’s Canterbury Park deferred stock award vest and be delivered?

The deferred stock award to Carin J. Offerman will vest at Canterbury Park’s 2027 Annual Meeting of Shareholders. Although vesting occurs then, the shares will not be delivered until one year after the vesting date, extending the compensation horizon.

How many Canterbury Park (CPHC) shares does Carin J. Offerman own after this Form 4 transaction?

After receiving the 2,547-share deferred stock award, Carin J. Offerman beneficially owns 118,852 shares of Canterbury Park common stock directly. This figure reflects her total reported holdings following the compensation grant disclosed in the Form 4 filing.

Is Carin J. Offerman’s CPHC transaction a market purchase or a compensation grant?

The transaction is a compensation grant, not a market purchase. It is coded as a grant or award acquisition, with 2,547 shares of common stock awarded at a price of $0.0000 per share, structured as a deferred stock award subject to future vesting and delivery.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/08/2026 - 10:52 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OFFERMAN CARIN J

(Last) (First) (Middle)

1100 CANTERBURY ROAD

(Street)

SHAKOPEE MINNESOTA 55379

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Canterbury Park Holding Corp [ CPHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		2,547(1)	A	$0	118,852	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred stock award vesting at the Company's 2027 Annual Meeting of Shareholders, but not delivered until one year from the vesting date. The number of shares to be issued was determined based on the closing price of $15.70 as of June 4, 2026.

	Alex Lorman by Power of Attorney for Carin J. Offerman	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)